Patent & IP news for April 26, 2016

Patent Litigations

USPTO Weekly Stats


Patent & IP Blogs

post image EPA and Commodities Commission Cooperate to Fight Biofuels Greenwashing from

Previous posts (e.g., here, here, here, and here) have covered a rash of fraudulent biofuels credits schemes in which companies falsely claim to produce biofuels and sell fake credits on the Renewable Identification Numbers ...

Share via E–mail | Twitter | Facebook

post image Federal Trade Secret Legislation Progresses from

Evan Talley

Last week, the Senate Judiciary Committee approved the Defend Trade Secrets Act of 2016 (S. 1890), priming the House of Representative for a vote on its companion bill, H.R. 3326. Before going ...

Share via E–mail | Twitter | Facebook

post image World IP Day - Anne Frank & Geo-blocking Special from

Click to enlargeYes, it's that time of year again. That special day in the calendar we've all been waiting for, noses pressed against the glass, it's finally World IP day!  [Merpel ...

Share via E–mail | Twitter | Facebook

post image Investing in Patents from

I’m sitting now with my copy of Russ Krajec‘s new book titled “Investing in Patents.” (released on April 26 on Amazon).  I have known Russ for more than a decade – throughout that time ...

Share via E–mail | Twitter | Facebook

WHO Debates Changes To Safeguards Against Undue Influence By Outside Actors from

This week a group of delegates at the UN World Health Organization is seeking to finalise an agreement on a draft framework defining the organisation’s relationships with external actors, such as philanthropy, the private ...

Share via E–mail | Twitter | Facebook

Storytelling in the 21st Century: An Interview with Hal Niedzviecki from

Hal Niedzviecki is a prolific novelist and cultural critic, as well as the founder of Broken Pencil. He is in the process of releasing The Archaeologists, his first novel in a decade, in a serialized ...

Share via E–mail | Twitter | Facebook

Innovative R&D Financing Discussed At Geneva Health Forum from

The recent Geneva Health Forum captured the fevered pitch in the larger ongoing conversation around innovative financing for research and development for public health. A new report on a voluntary pooled fund for neglected diseases ...

Share via E–mail | Twitter | Facebook

Irony? Publisher Celebrates IP By Revoking IP? from

There's no better way to celebrate something than by doing the opposite of it. That seems to be the message of the Edward Elgar publishing company. In a campaign today to hail the virtues ...

Share via E–mail | Twitter | Facebook

In US, Growing Battle Over Offensive Trademarks from

The US Patent and Trademark Office (USPTO) is not admitting defeat. It is still refusing to register trademarks that disparage people, even though this policy violates the First Amendment’s guarantee of free speech, according ...

Share via E–mail | Twitter | Facebook

PTAB Grants Motion to Amend Vehicle Wheel Hanger Patent from

The Board granted the patent owner's contingent motion to amend, granting entry of proposed claims 6-10 for original claims 1-5 which had been found unpatentable, because the proposed amended claims were patentable over the ...

Share via E–mail | Twitter | Facebook

Federal Circuit Rejects Reduced-Deference for AIA-Trial Decisions from

by Dennis Crouch En banc denials in Merck & Cie v. Gnosis (Fed. Cir. 2016) and S. Alabama Medical v. Gnosis (Fed. Cir. 2016) The Federal Circuit has denied en banc review of decisions in four ...

Share via E–mail | Twitter | Facebook

The AIA Is Not a Taking from

I have just published, along with Ben Picozzi, a response to Greg Dolin and Irina Manta's article, Taking Patents. In the response we refute Dolin and Manta's argument that the America Invents Act ...

Share via E–mail | Twitter | Facebook

Disclosure Of Origin Of Designs At Issue In Potential WIPO Treaty from

This week, World Intellectual Property Organization delegates are hoping to come closer on remaining issues in a potential treaty facilitating the registration of industrial designs for international applicants. This is easier said than done, though ...

Share via E–mail | Twitter | Facebook

Chance to reconsider use of COX-2 inhibitor rofecoxib? from

US Patent 6,063,811, assigned to Merck, has claims covering methods for the use of VIOXX:

1. A method of treating a disease susceptible to treatment with an non-steroidal anti-inflammatory agent comprising:

administration orally ...

Share via E–mail | Twitter | Facebook

Qualtrics, LLC v. OpinionLab, Inc. (PTAB 2016) from

Focusing on the Claims, the PTAB Denies CBM Review of a Market Research Patent By Joseph Herndon -- On April 13, 2016, the U.S. Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (PTAB ...

Share via E–mail | Twitter | Facebook

National Patent Prosecution Day . . . . from

I suppose that if there were ever to be a National Patent Prosecution Day, it would have to be celebrated on May 2nd.  After all, that is the anniversary of the Topliff v. Topliff decision ...

Share via E–mail | Twitter | Facebook

Some content © 2007–2016 RPX Corporation.
Terms of Service & Privacy Policy
For DMCA requests contact